N/A
Completed N=17
Acupuncture to Improve Comfort of Children on a Ventilator in the Intensive Care Unit
Source: ClinicalTrials.gov NCT01848158 ↗Enrolled (actual)
17
Serious AEs
0.0%
Results posted
Aug 2020
Primary outcomePrimary: Average Daily Dexmedetomidine mcg/kg/Day — 11.08; 17.42 mcg/kg/day
Summary
The purpose of this study is to determine whether acupuncture is effective at improving comfort in children on a ventilator in the intensive care unit. Our hypothesis is that the patients receiving acupuncture will require less medications to keep them comfortable than those who receive sham or fake acupuncture.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Average Daily Dexmedetomidine mcg/kg/Day |
11.08; 17.42 | — |
| PRIMARY Average Daily Morphine Equivalents (mg/kg/Day) |
1.04; 1.61 | — |
| PRIMARY Average Daily Midazolam Equivalents (mg/kg/Day) |
0.73; 0.97 | — |
| PRIMARY Average Daily Sedation Score |
29.0; 43.4 | — |
| SECONDARY Number of Participants With Skin Ulceration at Acupuncture/Sham Sites |
0; 0 | — |
| SECONDARY Number of Participants With Hematoma at Acupuncture/Sham Sites |
0; 0 | — |
| SECONDARY Number of Participants With Cellulitis at Acupuncture/Sham Sites |
0; 0 | — |
| SECONDARY Number of Participants Who Are Diagnosed With Bacteremia During the Study |
0; 0 | — |
| SECONDARY Number of Participants Who Are Diagnosed With Septic Shock During the Study |
0; 0 | — |
| SECONDARY Death While Enrolled in Study |
0; 0 | — |
Eligibility Criteria
Inclusion Criteria
- age ≥6 months to 4mg/kg/day}, or immunosuppressive biologics {e.g., thymoglobulin, etanercept, infliximab, adalimumab, rituximab})
Data sourced from ClinicalTrials.gov (NCT01848158). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.